NCT00079859 - Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

April 30, 2005

Conditions

Familial Hypercholesterolemia

Interventions

DRUG

Implitapide

Trial Locations (6)

Metabolic and Atherosclerosis Research Center, Cincinnati

Andromed Leiden, Leiden

Andromed Rotterdam, Rotterdam

Andromed Oost, Velp

Andromed Zoetermeer, Zoetermeer

Lipidklinikken - Rikshospitalet, Oslo